Overview

Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the vaccination protocol is to induce specific immune responses against melanoma associated antigens by intradermal injections of mRNA coding for the corresponding antigen.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Hospital Tuebingen
Collaborator:
German Research Foundation
Treatments:
Vaccines